UNSPSC 51334301: Chlorprothixene

This classification denotes an antipsychotic agent with the molecular formula C18H18ClNS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9S7OD60EWP, chemically known as 3-(2-chlorothioxanthen-9-ylidene)-n,n-dimethyl-propan-1-amine but generally known as chlorprothixene, which bears US NIH Compound Identifier 2729. European Medicines Agency schedules Chlorprothixene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06210MIG.

UNSPSC 51334301 Chlorprothixene, a Commodity code, nominally covers a specific antipsychotic pharmaceutical, but recent state and local procurement activity tagged under this code shows minimal relevance to the nominal product. The single recent opportunity available reflects a substantial mismatch: Seminole County, Florida's IFB 60459723LAS solicits Naloxone and Safe Drug Deactivation Systems—opioid-reversal medication and harm-reduction equipment—rather than chlorprothixene. This divergence suggests either a cataloging error at the county level or that the code is being applied to a broader pharmaceutical or public-health procurement category than its name indicates. State and local governments typically use UNSPSC codes to classify purchases for budget and vendor-management purposes, and when misalignment occurs between code nomenclature and actual solicitation scope, it signals a need for careful source verification before pursuing opportunities under this code designation.

Seminole County's IFB, posted June 30, 2026, with response due July 26, 2026, seeks annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems for quarterly delivery to the Seminole County Community Health Building in Sanford, Florida. The contract carries a two-year initial term with a one-year renewal option, fixed-fee pricing, and standard compliance requirements including drug-free workplace certification, E-Verify authorization, and workers' compensation and commercial general liability insurance. The opportunity does not designate set-asides for disadvantaged enterprises. No other recent state or local opportunities appear in the available record under this code; the single Seminole County solicitation is the only current activity. Given the code–opportunity mismatch and the absence of a broader opportunity pipeline, this code shows little actionable activity for vendors seeking consistent procurement under the chlorprothixene or related pharmaceutical classifications.